ResMed Inc.
RMD
Rangering i aksjer
#723
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Aksjekurs
$239.62
Markedsverdi
$33.70B
Endring (1 dag)
0.48%
Endring (1 år)
-10.62%
Land
US
Handel ResMed Inc. (RMD)
Kategori
Healthcare
Driftsmargin for ResMed Inc. (RMD)
Driftsmargin per October 2026 TTM: 33.48%
Ifølge ResMed Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 33.48%. Ved slutten av 2024 hadde selskapet en driftsmargin på 28.17%.
Historikk for driftsmargin for ResMed Inc. fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 33.48% | 2.23% |
| 2025 | 32.75% | 16.26% |
| 2024 | 28.17% | 5.11% |
| 2023 | 26.80% | -4.15% |
| 2022 | 27.96% | -1.10% |
| 2021 | 28.27% | 3.25% |
| 2020 | 27.38% | 23.22% |
| 2019 | 22.22% | -4.02% |
| 2018 | 23.15% | 12.38% |
| 2017 | 20.60% | -11.70% |
| 2016 | 23.33% | -4.31% |
| 2015 | 24.38% | -6.41% |
| 2014 | 26.05% | 11.18% |
| 2013 | 23.43% | 8.93% |
| 2012 | 21.51% | 0.19% |
| 2011 | 21.47% | -2.45% |
| 2010 | 22.01% | 6.48% |
| 2009 | 20.67% | 20.81% |
| 2008 | 17.11% | 35.90% |
| 2007 | 12.59% | -41.79% |
| 2006 | 21.63% | -5.46% |
| 2005 | 22.88% | -9.06% |
| 2004 | 25.16% | 2.36% |
| 2003 | 24.58% | -198.05% |
| 2002 | -25.07% | -249.40% |
| 2001 | 16.78% | -41.45% |
| 2000 | 28.66% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 17.03% | -99.49% |
US
|
|
| 17.86% | -99.47% |
IE
|
|
| 22.03% | -99.34% |
US
|
|
| 21.46% | -99.36% |
US
|
|
| 0.00% | - |
DE
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.